Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) has advised Hasten Biopharmaceuticals on its acquisition of 14 product portfolios from Korean biopharmaceutical company Celltrion Healthcare.
Hasten Biopharmaceuticals is a leading specialty pharmaceutical company based in China and a portfolio company of CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore.
The Freshfields team advising on the transaction was led by partner Alan Wang and counsel Ya Ma, supported by associates Sunny Min and Yichen Xing. Teams in Europe provided support on IP matters and various commercial agreements, comprised by partners David Brooks and Philipp Dohnke, counsel Philipp Lehman and John Scurr, senior associate Ben Cohen and associate Babak Hakimian.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
